| 000 | 01748 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513185054.0 | ||
| 264 | 0 | _c19990715 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/(sici)1097-0142(19990701)86:1<64::aid-cncr11>3.0.co;2-# _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHickok, J T | |
| 245 | 0 | 0 |
_aUse of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. _h[electronic resource] |
| 260 |
_bCancer _cJul 1999 |
||
| 300 |
_a64-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBreast Neoplasms, Male _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVomiting, Anticipatory _xchemically induced |
| 700 | 1 | _aRoscoe, J A | |
| 700 | 1 | _aMorrow, G R | |
| 700 | 1 | _aStern, R M | |
| 700 | 1 | _aYang, B | |
| 700 | 1 | _aFlynn, P J | |
| 700 | 1 | _aHynes, H E | |
| 700 | 1 | _aKirshner, J J | |
| 700 | 1 | _aRosenbluth, R J | |
| 773 | 0 |
_tCancer _gvol. 86 _gno. 1 _gp. 64-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0142(19990701)86:1<64::aid-cncr11>3.0.co;2-# _zAvailable from publisher's website |
| 999 |
_c10349894 _d10349894 |
||